IVD Contract Manufacturing Market Size, Share, Opportunities, And Trends By Device Type (IVD Equipment, IVD Consumables), By Service Type (Manufacturing Services, Assay Development Services, Other Services), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others), And By Geography - Forecasts From 2024 To 2029

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. IVD CONTRACT MANUFACTURING MARKET BY DEVICE TYPE

5.1. Introduction

5.2. IVD Equipment

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.3. IVD Consumables

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

6. IVD CONTRACT MANUFACTURING MARKET BY SERVICE TYPE

6.1. Introduction

6.2. Manufacturing Services

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. Assay Development Services

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.4. Other Services

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

7. IVD CONTRACT MANUFACTURING MARKET BY TECHNOLOGY

7.1. Introduction

7.2. Immunoassay

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.3. Clinical Chemistry

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

7.4. Molecular Diagnostics

7.4.1. Market Trends and Opportunities

7.4.2. Growth Prospects

7.5. Microbiology

7.5.1. Market Trends and Opportunities

7.5.2. Growth Prospects

7.6. Hematology

7.6.1. Market Trends and Opportunities

7.6.2. Growth Prospects

7.7. Coagulation & Hemostasis

7.7.1. Market Trends and Opportunities

7.7.2. Growth Prospects

7.8. Others

7.8.1. Market Trends and Opportunities

7.8.2. Growth Prospects

8. IVD CONTRACT MANUFACTURING MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Device Type

8.2.2. By Service Type

8.2.3. By Technology

8.2.4. By Country

8.2.4.1. United States

8.2.4.1.1. Market Trends and Opportunities

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Trends and Opportunities

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Trends and Opportunities

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Device Type

8.3.2. By Service Type

8.3.3. By Technology

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Trends and Opportunities

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Trends and Opportunities

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Trends and Opportunities

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Device Type

8.4.2. By Service Type

8.4.3. By Technology

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Trends and Opportunities

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Trends and Opportunities

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Trends and Opportunities

8.4.4.3.2. Growth Prospects

8.4.4.4. Italy

8.4.4.4.1. Market Trends and Opportunities

8.4.4.4.2. Growth Prospects

8.4.4.5. Spain

8.4.4.5.1. Market Trends and Opportunities

8.4.4.5.2. Growth Prospects

8.4.4.6. Others

8.4.4.6.1. Market Trends and Opportunities

8.4.4.6.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Device Type

8.5.2. By Service Type

8.5.3. By Technology

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Trends and Opportunities

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Trends and Opportunities

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Trends and Opportunities

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Device Type

8.6.2. By Service Type

8.6.3. By Technology

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Trends and Opportunities

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Trends and Opportunities

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Trends and Opportunities

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Trends and Opportunities

8.6.4.4.2. Growth Prospects

8.6.4.5. Taiwan

8.6.4.5.1. Market Trends and Opportunities

8.6.4.5.2. Growth Prospects

8.6.4.6. Thailand

8.6.4.6.1. Market Trends and Opportunities

8.6.4.6.2. Growth Prospects

8.6.4.7. Indonesia

8.6.4.7.1. Market Trends and Opportunities

8.6.4.7.2. Growth Prospects

8.6.4.8. Others

8.6.4.8.1. Market Trends and Opportunities

8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Thermo Fisher Scientific Inc.

10.2. Siemens Healthineers AG

10.3. Danaher Corporation

10.4. Roche Diagnostics

10.5. Abbott Laboratories

10.6. Bio-Rad Laboratories, Inc.

10.7. Sysmex Corporation

10.8. Quidel Corporation

10.9. BioMérieux SA